Abstract

A series of mono-, di- and triorganotin compounds with general formulae [RSnL(2)Cl], R = Bu (compound 3), [R(2)SnL(2)], where R = Me, Et, Bu, Oct (compounds 1, 2, 4 and 6) and [R(3)SnL], where R = Bu, Cy and Ph (compounds 5, 7 and 8) and where L = 3,4-methylenedioxy-6-nitrophenylpropenoic acid have been prepared and characterized by elemental analysis, multinuclear ((1)H-, (13)C- and (119)Sn-) NMR and mass spectrometry. The ligand and its respective organotin complexes were screened for cytotoxicity using the brine shrimp lethality assay and for antitumor activity using the crown gall tumor inhibition (potato disc) assay. The bioassay results support the conclusion that the biological activities of these synthetic compounds are in the following order: [RSnL(2)Cl] < [R(2)SnL(2)] < [R(3)SnL].

Highlights

  • Organotin (IV) complexes are extensively used as catalysts, stabilizers, biocides, antifouling agents and as wood preservatives [1,2,3,4,5]

  • The ligand L and its organotin (IV) derivatives have been screened for cytotoxicity using the brine shrimp lethality assay and for antitumor activity with the crown gall tumor inhibition assay

  • Mono, di- and triorganotin complexes were synthesized by refluxing stoichiometric amounts of the ligand acid, R'COOH, with the corresponding oxides/hydroxides (Procedure I) or its sodium salt with the corresponding organotin chlorides in toluene (Procedure II), as summarized in equations I-V

Read more

Summary

Introduction

Organotin (IV) complexes are extensively used as catalysts, stabilizers, biocides, antifouling agents and as wood preservatives [1,2,3,4,5]. The ligand L and its organotin (IV) derivatives have been screened for cytotoxicity using the brine shrimp lethality assay and for antitumor activity with the crown gall tumor inhibition assay (potato disc assay).

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.